Topics

BMS, Nektar broaden development program for bempeg-nivolumab combo

04:59 EST 14 Jan 2020 | SmartBrief

Testing of Nektar's bempeg, or bempegaldesleukin, and Bristol-Myers Squibb's Opdivo, or nivolumab, will be expanded as part o -More

Original Article: BMS, Nektar broaden development program for bempeg-nivolumab combo

NEXT ARTICLE

More From BioPortfolio on "BMS, Nektar broaden development program for bempeg-nivolumab combo"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...